Skip to content
Citation only via OpenAlex

Assessment of IL‐1β, IL‐6, TNF‐α, IL‐8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis

Wael Alturaiki, Abdulaziz Alhamad, Muath Alturaiqy, Shabir Ahmad Mir, Danish Iqbal, Abdul Aziz Bin Dukhyil, Mohammed Alaidarous, Bader Alshehri, Suliman Abdallah Alsagaby, Sami G. Almalki, Fayez Alghofaili, Ranjay Kumar Choudhary, Saeedah Musaed Almutairi, Saeed Banawas, Bandar Alosaimi

International Journal of Rheumatic Diseases · 2022 · ▲ 39 citations

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder which mainly affects small joints, occurs most commonly in middle-aged adults, and can be fatal in severe cases. The exact etiology of RA remains unknown. However, uncontrolled expression of pro-inflammatory cytokines and chemokines can contribute to the pathogenesis of RA. AIM: In the current study, we assessed the potential of serum concentrations of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, IL-8, and C-C motif chemokine ligand (CCL)5 as early predictive markers for RA. METHODS: In addition to clinical examination, blood samples were collected from 100 Saudi patients recently diagnosed with early RA for basic and serological tests, including rheumatoid factor (RF), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). Sera of 32 healthy individuals were used as controls. Specific enzyme-linked immunosorbent assay was used to quantify the serum IL-1β, IL-6, TNF-α, IL-8, and CCL5 levels in the samples. RESULTS: Our results indicated that RF, CRP, and ESR levels were higher in RA patients compared to controls. Furthermore, serum levels of IL-1β, IL-6, IL-8, and CCL5, but not TNF-α, significantly increased in RA patients compared to controls. CONCLUSION: Overall, the findings suggested that IL-1β, IL-6, IL-8, and CCL5 can be used as biomarkers in the early diagnosis of RA.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/1756-185x.14373
Canonical
link ↗
Fetched
2026-10-15 MST

Cite this

APA
Alturaiki, W., Alhamad, A., Alturaiqy, M., Mir, S.A., Iqbal, D., Dukhyil, A.A.B., Alaidarous, M., Alshehri, B., Alsagaby, S.A., Almalki, S.G., Alghofaili, F., Choudhary, R.K., Almutairi, S.M., Banawas, S., Alosaimi, B., &amp; Mubarak, A. (2022). Assessment of IL‐1β, IL‐6, TNF‐α, IL‐8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis. <em>International Journal of Rheumatic Diseases</em>. https://doi.org/10.1111/1756-185x.14373
Vancouver
Alturaiki W, Alhamad A, Alturaiqy M, Mir SA, Iqbal D, Dukhyil AAB, et al. Assessment of IL‐1β, IL‐6, TNF‐α, IL‐8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis. International Journal of Rheumatic Diseases. 2022. doi:10.1111/1756-185x.14373.
BibTeX
@article{wael2022Assess, title = {Assessment of IL‐1β, IL‐6, TNF‐α, IL‐8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritis}, author = {Wael Alturaiki and Abdulaziz Alhamad and Muath Alturaiqy and Shabir Ahmad Mir and Danish Iqbal and Abdul Aziz Bin Dukhyil and Mohammed Alaidarous and Bader Alshehri and Suliman Abdallah Alsagaby and Sami G. Almalki and Fayez Alghofaili and Ranjay Kumar Choudhary and Saeedah Musaed Almutairi and Saeed Banawas and Bandar Alosaimi and Ayman Mubarak}, journal = {International Journal of Rheumatic Diseases}, year = {2022}, doi = {10.1111/1756-185x.14373}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings